130 related articles for article (PubMed ID: 15860859)
1. Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement.
McLean TW; Fisher CJ; Snively BM; Chauvenet AR
J Clin Oncol; 2005 May; 23(13):3024-9. PubMed ID: 15860859
[TBL] [Abstract][Full Text] [Related]
2. The safety of central line placement prior to treatment of pediatric acute lymphoblastic leukemia.
Carr E; Jayabose S; Stringel G; Slim M; Ozkaynak MF; Tugal O; Sandoval C
Pediatr Blood Cancer; 2006 Dec; 47(7):886-8. PubMed ID: 16200633
[TBL] [Abstract][Full Text] [Related]
3. Placing of tunneled central venous catheters prior to induction chemotherapy in children with acute lymphoblastic leukemia.
Handrup MM; Møller JK; Frydenberg M; Schrøder H
Pediatr Blood Cancer; 2010 Aug; 55(2):309-13. PubMed ID: 20582964
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study.
Abbas AA; Fryer CJ; Paltiel C; Chedid F; Felimban SK; Yousef AA; Khattab TM
Pediatr Blood Cancer; 2004 Apr; 42(4):325-31. PubMed ID: 14966828
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer.
Athale U; Siciliano S; Thabane L; Pai N; Cox S; Lathia A; Khan A; Armstrong A; Chan AK
Pediatr Blood Cancer; 2008 Dec; 51(6):792-7. PubMed ID: 18798556
[TBL] [Abstract][Full Text] [Related]
6. Significant association with location of central venous line placement and risk of venous thrombosis in children.
Male C; Julian JA; Massicotte P; Gent M; Mitchell L;
Thromb Haemost; 2005 Sep; 94(3):516-21. PubMed ID: 16268465
[TBL] [Abstract][Full Text] [Related]
7. Timing of Central Venous Line Insertion During Induction in Children With Acute Lymphoblastic Leukemia.
Ataseven E; Yilmaz Ş; Tüfekçi Ö; Ören H
J Pediatr Hematol Oncol; 2023 Jan; 45(1):25-28. PubMed ID: 36598960
[TBL] [Abstract][Full Text] [Related]
8. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
[TBL] [Abstract][Full Text] [Related]
9. Central line-related sepsis in acute burn patients.
Still JM; Law E; Thiruvaiyaru D; Belcher K; Donker K
Am Surg; 1998 Feb; 64(2):165-70. PubMed ID: 9486891
[TBL] [Abstract][Full Text] [Related]
10. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study.
Ruud E; Holmstrøm H; de Lange C; Natvig S; Albertsen BK; Wesenberg F
Pediatr Hematol Oncol; 2006; 23(3):207-16. PubMed ID: 16517537
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
Oudot C; Auclerc MF; Levy V; Porcher R; Piguet C; Perel Y; Gandemer V; Debre M; Vermylen C; Pautard B; Berger C; Schmitt C; Leblanc T; Cayuela JM; Socie G; Michel G; Leverger G; Baruchel A
J Clin Oncol; 2008 Mar; 26(9):1496-503. PubMed ID: 18349402
[TBL] [Abstract][Full Text] [Related]
13. Central venous line-related thrombosis in children: association with central venous line location and insertion technique.
Male C; Chait P; Andrew M; Hanna K; Julian J; Mitchell L;
Blood; 2003 Jun; 101(11):4273-8. PubMed ID: 12560228
[TBL] [Abstract][Full Text] [Related]
14. Wireless replacement of the "lost" central venous line in children.
Somme S; Gedalia U; Caceres M; Hill CB; Liu DC
Am Surg; 2001 Sep; 67(9):817-9; discussion 819-20. PubMed ID: 11565756
[TBL] [Abstract][Full Text] [Related]
15. Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies--a randomized, controlled study.
Ruud E; Holmstrøm H; De Lange C; Hogstad EM; Wesenberg F
Acta Paediatr; 2006 Sep; 95(9):1053-9. PubMed ID: 16938749
[TBL] [Abstract][Full Text] [Related]
16. Thrombosis and acute lymphoblastic leukaemia.
Payne JH; Vora AJ
Br J Haematol; 2007 Aug; 138(4):430-45. PubMed ID: 17608766
[TBL] [Abstract][Full Text] [Related]
17. Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia.
Meister B; Kropshofer G; Klein-Franke A; Strasak AM; Hager J; Streif W
Pediatr Blood Cancer; 2008 Feb; 50(2):298-303. PubMed ID: 17443678
[TBL] [Abstract][Full Text] [Related]
18. Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemia.
Hill G; Chauvenet AR; Lovato J; McLean TW
Pediatrics; 2005 Oct; 116(4):e525-9. PubMed ID: 16199681
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for early catheter-related infections in cancer patients.
Penel N; Neu JC; Clisant S; Hoppe H; Devos P; Yazdanpanah Y
Cancer; 2007 Oct; 110(7):1586-92. PubMed ID: 17685401
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
Ribera JM; Oriol A; Sanz MA; Tormo M; Fernández-Abellán P; del Potro E; Abella E; Bueno J; Parody R; Bastida P; Grande C; Heras I; Bethencourt C; Feliu E; Ortega JJ
J Clin Oncol; 2008 Apr; 26(11):1843-9. PubMed ID: 18398150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
